The invention provides methods and pharmaceutical compositions for treating cancer or promoting apoptosis of cancer cells, or reducing the resistance of cancer cells to chemotherapy or apoptosis-promoting therapies by contacting the cancer cells with an ENTPD5-specific inhibitor.
申请公布号
WO2012065139(A3)
申请公布日期
2013.02.21
申请号
WO2011US60487
申请日期
2011.11.11
申请人
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM;WANG, XIAODONG;MACMILLAN, JOHN B.;HUANG, SONG;FANG, MIN
发明人
WANG, XIAODONG;MACMILLAN, JOHN B.;HUANG, SONG;FANG, MIN
